| Year | 2023 | 2022 |
|---|---|---|
| Total Revenue | 5.69B | 5.17B |
| Cost of Revenue | 3.52B | 3.39B |
| Gross Profit | 2.17B | 1.78B |
| Operating Expenses | 261.15M | 694.56M |
| Research and Development | 0 | 6.05M |
| Selling, General & Administrative Expenses | 250.78M | 124.53M |
| Selling & Marketing Expenses | 6.17M | 84.87M |
| General & Administrative Expenses | 244.61M | 39.66M |
| Other Expenses | 0 | 73.04M |
| Operating Income | 1.91B | 1.09B |
| Total Other Income/Expenses Net | -336.62M | -384.66M |
| Income Before Tax | 1.58B | 1.15B |
| Income Tax | 365.42M | 252.44M |
| Net Income | 1.2B | 883.16M |
| Basic EPS | 10.82 | 7.97 |
| EPS Diluted | 10.82 | 7.97 |
| Basic Average Shares | 110.73M | 110.75M |
| Diluted Average Shares | 110.75M | 110.75M |
| EBITDA | 1.65B | 1.13B |
Fineotex Chemical Limited
FCL.NS
NSE
227.57INR9.07 (3.70%)
FCL.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 3.15B | 2.31B |
| Net Income | 1.2B | 883.16M |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -225.98M | -58.89M |
| Retained Earnings | 4.3B | 3.15B |
| Other Distributions | 930.45M | 779.99M |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 1.31B | 891.64M |
| Annual Depreciation | 60.2M | 42.8M |
| Capital Expenditure | -479.05M | -194.35M |
| Net PPE | 1.73B | 1.04B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 0 | 0 |
| Goodwill (Previous Year) | 61.39M | 61.39M |
| Goodwill | 61.39M | 61.39M |